We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Walmart, Target, Home Depot and NVIDIA are part of Zacks Earnings Preview
Read MoreHide Full Article
For Immediate Release
Chicago, IL – August 17, 2020 – Zacks.com releases the list of companies likely to issue earnings surprises. This week’s list includes Walmart Inc. (WMT - Free Report) , Target Corporation (TGT - Free Report) , The Home Depot, Inc. (HD - Free Report) and NVIDIA Corporation (NVDA - Free Report) .
Can the Earnings Picture Continue to Improve?
We have consistently been pointing out the improving trend in the overall earnings picture ever since the Q2 earnings season got underway last month. While earnings took a big hit in Q2, as was expected all along, the impact turned out to be less significant than initially projected. Importantly, this slightly less rough view is not confined to the second quarter, but also extending to the current period (2020 Q3) and beyond.
All of this is in-line with what we are seeing in macroeconomic data as well that shows the U.S. economy steadily coming out of the pandemic-driven downturn. We saw this in recent readings about retail sales, jobs, and the factory sector that all show steady momentum.
We all know that a big support for the economy has been the extraordinary fiscal and monetary measures that were put in place in the wake of the pandemic. But a number of these supports have either ended or are coming to an end in the near future. The worry is that the recovery may lose some of its steam if the fiscal support measures are not extended, particularly for those parts of the economy that are expected to remain down for quite some time.
Beyond the macro issues, we discuss the overall earnings story that emerged out of the Q2 earnings season, now winding down, through the following charts.
Please note that through Friday, August 14th, we have seen Q2 results from 458 S&P 500 members or 91.6% of the index’s total membership. We have another 18 index members on deck to report results this week, including Walmart, Target, Home Depot, Nvidia and others.
Total earnings (or aggregate net income) for the 458 S&P 500 members are down -35.4% on -11.3% lower revenues. To round out this scorecard, 79.7% of these 458 index members have beaten consensus EPS estimates and the corresponding revenue beats percentage is 62.9%, with a blended beats percentage of 55.7%.
Q3 earnings for the S&P 500 index are currently expected to decline -24% from the same period last year. But the growth picture has been steadily improving since the start of July. We see a similar trend in place for 2020 Q4 and full-year 2020 estimates as well.
This is a notable improvement in the overall earnings picture since the start of the pandemic and is in-line with high-frequency macroeconomic data that is showing a similar improvement in the economy’s growth drivers.
The question at this stage is the extent of damage to this improving as a result of Congress’ inability to extend the pandemic-related relief measures that played a critical role in stabilizing the economic picture.
As would be expected, 2020 estimates came down as the pandemic unfolded, with the current -21.3% decline down from +7.9% growth at the start of the year. But as we mentioned earlier in the context of 2020 Q3 estimates, the revisions trend lately has been positive.
For an in-depth look at the overall earnings picture and expectations for the coming quarters, please check out our weekly Earnings Trends report >>>> Looking Ahead to a Better Earnings Picture
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss.This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performancefor information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Walmart, Target, Home Depot and NVIDIA are part of Zacks Earnings Preview
For Immediate Release
Chicago, IL – August 17, 2020 – Zacks.com releases the list of companies likely to issue earnings surprises. This week’s list includes Walmart Inc. (WMT - Free Report) , Target Corporation (TGT - Free Report) , The Home Depot, Inc. (HD - Free Report) and NVIDIA Corporation (NVDA - Free Report) .
Can the Earnings Picture Continue to Improve?
We have consistently been pointing out the improving trend in the overall earnings picture ever since the Q2 earnings season got underway last month. While earnings took a big hit in Q2, as was expected all along, the impact turned out to be less significant than initially projected. Importantly, this slightly less rough view is not confined to the second quarter, but also extending to the current period (2020 Q3) and beyond.
All of this is in-line with what we are seeing in macroeconomic data as well that shows the U.S. economy steadily coming out of the pandemic-driven downturn. We saw this in recent readings about retail sales, jobs, and the factory sector that all show steady momentum.
We all know that a big support for the economy has been the extraordinary fiscal and monetary measures that were put in place in the wake of the pandemic. But a number of these supports have either ended or are coming to an end in the near future. The worry is that the recovery may lose some of its steam if the fiscal support measures are not extended, particularly for those parts of the economy that are expected to remain down for quite some time.
Beyond the macro issues, we discuss the overall earnings story that emerged out of the Q2 earnings season, now winding down, through the following charts.
Please note that through Friday, August 14th, we have seen Q2 results from 458 S&P 500 members or 91.6% of the index’s total membership. We have another 18 index members on deck to report results this week, including Walmart, Target, Home Depot, Nvidia and others.
Total earnings (or aggregate net income) for the 458 S&P 500 members are down -35.4% on -11.3% lower revenues. To round out this scorecard, 79.7% of these 458 index members have beaten consensus EPS estimates and the corresponding revenue beats percentage is 62.9%, with a blended beats percentage of 55.7%.
Q3 earnings for the S&P 500 index are currently expected to decline -24% from the same period last year. But the growth picture has been steadily improving since the start of July. We see a similar trend in place for 2020 Q4 and full-year 2020 estimates as well.
This is a notable improvement in the overall earnings picture since the start of the pandemic and is in-line with high-frequency macroeconomic data that is showing a similar improvement in the economy’s growth drivers.
The question at this stage is the extent of damage to this improving as a result of Congress’ inability to extend the pandemic-related relief measures that played a critical role in stabilizing the economic picture.
As would be expected, 2020 estimates came down as the pandemic unfolded, with the current -21.3% decline down from +7.9% growth at the start of the year. But as we mentioned earlier in the context of 2020 Q3 estimates, the revisions trend lately has been positive.
For an in-depth look at the overall earnings picture and expectations for the coming quarters, please check out our weekly Earnings Trends report >>>> Looking Ahead to a Better Earnings Picture
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss.This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performancefor information about the performance numbers displayed in this press release.